Hospital mortality of acute myocardial infarction in the thrombolytic era

Heart

Volumn 81, Issue 5, 1999, Pages 478-482

  Mahon, N G ^a   O'Rorke, C ^a   Codd, M B ^a   McCann, H A ^a   McGarry, K ^b   Sugrue, D D ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b Our Lady's Hospital   (Ireland)

Author keywords

Mortality; Myocardial infarction; Thrombolysis

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; COHORT ANALYSIS; FEMALE; HEART FAILURE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; SURVIVAL; TEACHING HOSPITAL;

EID: 0032905711     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.81.5.478     Document Type: Article

References (39)

1. 1 McGovern PG, Pankow JS, Shahar E, et al. Recent trends in acute coronary heart disease - mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. N Engl J Med 1996;334:884-90.
2. 2 Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993;328: 673-9.
3. 3 European Secondary Prevention Study Group. Translation of clinical trials into practice: a European population-based study of the use of thrombolysis for acute myocardial infarction. Lancet 1996;347:1203-7.
4. 4 Gray D, Keating N, Skene AM, et al. Myocardial infarction in patients over 75 1982-1990. Q J Med 1992;84:659-69.
5. 5 Farnsworth TA. Varying thrombolytic administration rates in elderly patients with acute myocardial infarction. Br J Clin Pract 1993;47:305-7.
6. 6 Fleming C, D'Agostino RB, Selker HP. Is coronary-care-unit admission restricted for elderly patients? A multicenter study. Am J Public Health 1991;81:1121-6.
7. 7 SAS User's Guide. 6.08. Cary, NC: SAS Institute Inc, 1989.
8. 8 Behar S, Barbash GI, Copel L, et al. Improved survival of hospitalized patients with acute myocardial infarction from 1981-1983 to 1992 in Israel. The SPRINT Study Group and The Israeli Thrombolytic Survey Group. Secondary prevention Israeli nifedipine trial. Coronary Art Dis 1994;5: 1001-7.
9. 9 Le Feuvre CA, Connolly SJ, Cairns JA, et al. Comparison of mortality from acute myocardial infarction between 1979 and 1992 in a geographically defined stable population. Am J Cardiol 1996;78:1345-9.
10. 10 Gheorghiade M, Ruzumna P, Borzak S, et al. Decline in the rate of hospital mortality from acute myocardial infarction: impact of changing management strategies. Am Heart J 1996;131:250-6.
11. 11 French JK, Williams BF, Hart HH, et al. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. BMJ 1996;312:1637-41.
12. 12 Mickelson JK, Blum CM, Geraci JM. Acute myocardial infarction: clinical characteristics, management and outcome in a metropolitan Veterans Affairs medical center teaching hospital. J Am Coll Cardiol 1997;29:915-25.
13. 13 Brown N, Young T, Gray D, et al. Inpatient deaths from acute myocardial infarction, 1982-92: analysis of data in the Nottingham heart attack register. BMJ 1896;315:159-64.
14. 14 Greenbaum RA, Morris R, Sritara P, et al. Reduced in-hospital mortality from acute myocardial infarction with general adoption of thrombolytic treatment in the North West Thames health region 1979-1991. Br Heart J 1995;74:493-6.
15. 15 Maynard C, Weaver WD, Litwin PE, et al. Hospital mortality in acute myocardial infarction in the era of reperfusion therapy (the myocardial infarction triage and intervention project). Am J Cardiol 1993;72:877-82.
16. 16 Capewell S, Kendrick S, Boyd J, et al. Measuring outcomes: one month survival after acute myocardial infarction in Scotland. Heart 1996;76:70-5.
17. 17 Morrison C, Woodward M, Leslie W, et al. Effect of socioeconomic group on incidence of, management of, and survival after myocardial infarction and coronary death: analysis of community coronary event register. BMJ 1997; 314:541-6.
18. 18 White HD, Barbash GI, Califf RM, et al. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global utilization of streptokinase and TPA for occluded coronary arteries trial. Circulation 1996; 94:1826-33.
19. 19 Aguirre FV, McMahon RP, Mueller H, et al. Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II study. TIMI II Investigators. Circulation 1994;90:78-86.
20. 20 Weaver WD, Litwin PE, Martin JS, et al. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. The MITI Project Group. J Am Coll Cardiol 1991;18:657-62.
21. 21 Goldberg RJ, Gorak EJ, Yarzebski J, et al. A community-wide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation 1993;87:1947-53.
22. 22 Greenland P, Reicher-Reiss H, Goldbourt U, et al. In-hospital and 1-year mortality in 1,524 women after myocardial infarction. Comparison with 4,315 men. Circulation 1991;83:484-91.
23. 23 Lincoff AM, Califf RM, Ellis SG, et al. Thrombolytic therapy for women with myocardial infarction: is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction Study Group. J Am Coll Cardiol 1993;22:1780-7.
24. 24 Batty GM, Parry DS, Wilkins WE, et al. Thrombolysis for elderly patients with myocardial infarction: experience in an integrated unit. Age Ageing 1994;23:220-2.
25. 25 Rosamond WD, Shahar E, McGovern PG, et al. Trends in coronary thrombolytic therapy for acute myocardial infarction (the Minnesota heart survey registry, 1990 to 1993). Am J Cardiol 1996;78:271-7.
26. 26 Rogers WJ, Bowlby LJ, Chandra NC, et al. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation 1994;90:2103-14.
27. 27 Rouleau JL, Moye LA, Pfeffer MA, et al. A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE Investigators. N Engl J Med 1993;328:779-84.
28. 28 Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S). Lancet 1994;344:1383-9.
29. 29 Barbash GI, White HD, Modan M, et al. Acute myocardial infarction in the young - the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Eur Heart J 1995;16:313-16.
30. 30 Vlietstra RE, Kronmal RA, Frye RL, et al. Factors affecting the extent and severity of coronary artery disease in patients enrolled in the coronary artery surgery study. Arteriosclerosis 1982;2:208-15.
31. 31 Schor S, Shani M, Modan B. Factors affecting immediate mortality of patients with acute myocardial infarction: a nationwide study. Chest 1975;68:217-21.
32. 32 Handley AJ, Teather D. Influence of smoking on deep vein thrombosis after myocardial infarction. BMJ 1974;iii: 230-1.
33. 33 de Chillou C, Riff P, Sadoul N, et al. Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: a multivariate analysis. J Am Coll Cardiol 1996;27:1662-8.
34. 34 Boden WE, O'Rourke RA, Crawford MH, et al. Outcomes in patients with acute non-Q wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med 1998;338: 1785-92.
35. 35 Yusuf S, Flather M, Pogue J, et al. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. Lancet 1998;352:507-14.
36. 36 The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. N Engl J Med 1989;320:618-27.
37. 37 Guadagnoli E, Hauptman PJ, Ayanian JZ, et al. Variation in the use of cardiac procedures after acute myocardial infarction. N Engl J Med 1995;333:573-8.
38. 38 Mark DB, Naylor CD, Hlatky MA, et al. Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med 1994;331:1130-5.
39. 39 Selby JV, Fireman BH, Lundstrom RJ, et al. Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. N Engl J Med 1996;335:1888-96.